Skip to main content
. 2023 Mar 11;11(2):228–241. doi: 10.1002/ueg2.12365

FIGURE 3.

FIGURE 3

Subgroup forest plots of DFS at 1, 2, and 3 years in patients with or without MVl who received PA‐TACE in different liver cancer stages after PSM. AJCC, American Joint Committee on Cancer; BCLC, Barcelona Clinic Liver Cancer; CNLC, China liver cancer; DFS, Disease‐free survival; HKLC, Hong Kong Liver Cancer; JIS, Japan Integrated Staging; MVI, Microvascular invasion; PA‐TACE, Postoperative adjuvant transarterial chemoembolization; PSM, Propensity score matching; TNM, Tumor Node Metastasis.